FDA Investigator Ying Xin Fan, PhD
Ying Xin Fan, PhD has inspections in 3 countries as of 26 May 2023. Ying Xin Fan, PhD has collaborated with a combinined 2233 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
26 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
Switzerland
Co-Investigator(s):
Alan R Condon,
Anastasia G Lolas,
Andrea Franco,
Andrew M Barlow,
Andrew W Harmon,
Angel K Sandhu,
Anh M Lac,
Ashar P Parikh,
Ashutosh Rao, PhD,
Bo Chi, PhD,
Brandon C Heitmeier,
Candace Y Gomez Broughton,
Carl Lee,
Carolyn A Renshaw,
CDR Rochelle B Young, RPh, MSA,
Charles L Zhou,
Charles R Cote, RIC,
Como,
Constance Lrichard Math,
Daniel L Zheng,
Diane L Raccasi,
Dorothy W Lee,
Dr. Ralph M Bernstein, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Edmund F Mrak, Jr,
Eileen A Liu,
Emmanuel Adu Gyamfi,
Erika V Butler,
Frances Namuswe, PhD,
Genoula K Ryan,
George T Allen, Jr,
Gerald B Seaborn, Jr,
Gregory R Brinsley,
Henry K Lau,
Herbert M Corbello,
Hung H Do, MS,
Ivan E Reyes,
Ivis L Negrón,
Ivis Lnegron Torres,
Jacob W Reynolds,
Jacqueline Mdiaz Albertini,
Jamie L Dion,
Janis R Armedoriz,
Jawaid Hamid,
Jee Chung, PhD,
Jeffrey M Watson,
Jeffry A Bernhardt,
Jianming Li,
Joan A Loreng,
Joel D Hosteos,
Joel D Hustedt,
John P Mistler,
Jolanna A Norton,
Jonathan G Matrisciano,
Jorge L Guadalupe,
Joslyn K Brunelle, PhD,
Juhong Liu, PhD,
Justin A Boyd,
Kalavati Suvarna, PhD,
Katherine Szestypalow,
Kevin A Gonzalez,
Kevin P Foley,
Kula N Jha,
Lance M De Souza, MBA,
Lane Christensen, PhD,
Lane V Christensen, PhD,
Laura Fontan, MS,
Libia M Lugo,
Lori B Wikstrom,
Madushini Dharmasena, PhD,
Maria Joselopez Barragan, PhD,
Marie A Fadden,
Marion Michaelis,
Mary E Storch,
Mary Jeanet Mcgarry,
Megan A Haggerty,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael Shanks, MS,
Michele Dougherty, PhD,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Monica Commerford, PhD,
Nadeem I Chaudhry,
Nicholas L Hunt,
Paraluman S Leonin,
Paula A Trost,
Prabhu P Raju,
Ramon E Martinez,
Raymond T Oji,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard H Penta,
Robert Rodriguez,
Rory K Geyer,
Sandra A Hughes,
Santos E Camara,
Scott R Nichols, PhD,
Sean R Marcsisin,
Sherri J Jackson,
Stacey S Degarmo,
Stephen R Souza,
Susan P Bruederle,
Tenzin Jangchup,
Thomas J Arista,
Thomas R Withers,
Tiara Nbrown Crosen,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vaishali J Patel,
Wayne E Seifert,
Wendy G Tan, PhD,
William Hallett, PhD,
William V Millar,
Xiaokuang Lai, PhD,
Yiyue Zhang (nmi), PhD,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Ying Xin Fan, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| December, 2016 | FDA 483 | KBI Biopharma, Inc. - Form 483, 2016-12-09 |
| December, 2017 | EIR | BioMarin Pharmaceutical Inc. - EIR, 2017-12-14 |
| December, 2017 | FDA 483 | BioMarin Pharmaceutical Inc. - Form 483, 2017-12-14 |
| May, 2023 | FDA 483 | Suzhou Union Biopharm Co., Ltd. - Form 483, 2023-05-26 |
| September, 2020 | FDA 483 | Genzyme Corporation - Form 483, 2020-09-04 |
| January, 2014 | FDA 483 | Kingchem Laboratories Inc. - Form 483, 2014-01-10 |
| September, 2020 | EIR | Genzyme Corporation - EIR, 2020-09-04 |
| October, 2019 | FDA 483 | Lonza AG - Form 483, 2019-10-18 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more